X-111312735-T-G
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001195553.2(DCX):c.948A>C(p.Ala316=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000852 in 1,209,215 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 25 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001195553.2 splice_region, synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -17 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DCX | NM_001195553.2 | c.948A>C | p.Ala316= | splice_region_variant, synonymous_variant | 6/7 | ENST00000636035.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DCX | ENST00000636035.2 | c.948A>C | p.Ala316= | splice_region_variant, synonymous_variant | 6/7 | 2 | NM_001195553.2 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000806 AC: 9AN: 111636Hom.: 0 Cov.: 22 AF XY: 0.0000887 AC XY: 3AN XY: 33808
GnomAD3 exomes AF: 0.0000764 AC: 14AN: 183253Hom.: 0 AF XY: 0.0000591 AC XY: 4AN XY: 67729
GnomAD4 exome AF: 0.0000856 AC: 94AN: 1097579Hom.: 0 Cov.: 30 AF XY: 0.0000606 AC XY: 22AN XY: 362945
GnomAD4 genome ? AF: 0.0000806 AC: 9AN: 111636Hom.: 0 Cov.: 22 AF XY: 0.0000887 AC XY: 3AN XY: 33808
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Invitae | Jan 12, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 28, 2019 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 26, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at